GLP-1 use is safe and effective to treat overweight and obese patients specifically those with a BMI of 25 or higher
mCRPC, Metastatic castration-resistant prostate cancer
Baseline reproductive hormone panels, semen analysis, metabolic labs, and blood counts depend on the peptide profile
Skipping steps or accelerating the timeline almost always leads to intolerable nausea, vomiting, or diarrhea
Among other variables, three studies [24, 26, 27] have recorded patient views on the administration route, and record a high level of acceptance of the oral route, the advantages of which include avoiding the displacement of patients to receive injections, avoiding the discomfort of injection, and a reduction in treatment costs [28, 29]